Detroit cancer center unveils new device for treating liver cancer at home
A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...
Liver Metastasis Treatment Market to Reach US$ 3.3 Billion, Growing at 6.5% CAGR by 2034 | Fact.MR Report
Growing demand for sophisticated and personalized treatment options to cure liver metastasis is expected to boost the market.Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...
International Business Times3h
A New Dawn in Cancer Treatment: Immunocine Gives Hope Through Its Revolutionary Immunotherapy
Now, eight years later, Chris credits the treatment with saving his life, calling it nothing short of miraculous. Another ...
Healthline13d
Symptoms of Late Stage Metastatic Breast Cancer
Treatment for metastatic breast cancer varies depending on where the ... Metastases in the lungs, brain, bones, or liver might each cause different symptoms. Becoming familiar with these symptoms ...
Hosted on MSN11d
Researchers link foodborne toxin to colorectal cancer metastasis
Metastases, or secondary growths formed away from the initial cancer site, are the primary cause of death from cancer, and ...
Medscape3h
T-DXd Shows Consistent Benefit Across Endocrine-Resistant HR+/HER2-Low Breast Cancer Subgroups
New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...
Business Wire9d
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...
News Medical on MSN13d
Extracellular vesicle DNA regulates immune responses and suppresses liver metastasis
The study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal ...
Managed Healthcare Executive6d
Two New FDA Approvals in Lung Cancer
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
manilatimes1d
Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Coherus BioSciences, Inc. ("Coherus,” NASDAQ: CHRS) today announced that an abstract highlighting final clinical and biomarker data from its Phase 2 clinical trial evaluating casdozokitug (casdozo), a ...